Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angel A Rodriguez

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Breast Cancer Research : BCR|April 8, 2015
Inhibition of iNOS as a novel effective targeted therapy against triple-negative breast cancerSergio Granados-Principal, Yi Liu, Maria L Guevara, et al.
Annals of Surgical Oncology|July 23, 2025
Circulating Tumor DNA (ctDNA) is Reliably Detected in Patients with Metastatic Malignant Phyllodes Tumors, a Feasibility StudyEllery H Reason, Michael D Aiduk, Amanda L Nash, et al.
Molecular Cancer|July 10, 2010
Characterizing cancer cells with cancer stem cell-like features in 293T human embryonic kidney cellsBisrat G Debeb, Xiaomei Zhang, Savitri Krishnamurthy, et al.
Breast Cancer Research : BCR|September 4, 2019
A randomized, controlled phase II trial of neoadjuvant ado-trastuzumab emtansine, lapatinib, and nab-paclitaxel versus trastuzumab, pertuzumab, and paclitaxel in HER2-positive breast cancer (TEAL study)Tejal A Patel, Joe E Ensor, Sarah L Creamer, et al.
Stem Cells (Dayton, Ohio)|May 10, 2014
Chloroquine eliminates cancer stem cells through deregulation of Jak2 and DNMT1Dong Soon Choi, Elvin Blanco, Yoo-Shin Kim, et al.
BMC Cancer|August 15, 2024
Monitoring response to neoadjuvant chemotherapy in triple negative breast cancer using circulating tumor DNAJennifer H Chen, Sridevi Addanki, Dhruvajyoti Roy, et al.
Science Translational Medicine|December 15, 2021
A phase 1/2 clinical trial of the nitric oxide synthase inhibitor L-NMMA and taxane for treating chemoresistant triple-negative breast cancerAndrew W Chung, Kartik Anand, Ann C Anselme, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2018
Identification of Incidental Germline Mutations in Patients With Advanced Solid Tumors Who Underwent Cell-Free Circulating Tumor DNA SequencingThomas P Slavin, Kimberly C Banks, Darya Chudova, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Breast Cancer Research : BCR|April 8, 2015
Inhibition of iNOS as a novel effective targeted therapy against triple-negative breast cancerSergio Granados-Principal, Yi Liu, Maria L Guevara, et al.
Annals of Surgical Oncology|July 23, 2025
Circulating Tumor DNA (ctDNA) is Reliably Detected in Patients with Metastatic Malignant Phyllodes Tumors, a Feasibility StudyEllery H Reason, Michael D Aiduk, Amanda L Nash, et al.
Molecular Cancer|July 10, 2010
Characterizing cancer cells with cancer stem cell-like features in 293T human embryonic kidney cellsBisrat G Debeb, Xiaomei Zhang, Savitri Krishnamurthy, et al.
Breast Cancer Research : BCR|September 4, 2019
A randomized, controlled phase II trial of neoadjuvant ado-trastuzumab emtansine, lapatinib, and nab-paclitaxel versus trastuzumab, pertuzumab, and paclitaxel in HER2-positive breast cancer (TEAL study)Tejal A Patel, Joe E Ensor, Sarah L Creamer, et al.
Stem Cells (Dayton, Ohio)|May 10, 2014
Chloroquine eliminates cancer stem cells through deregulation of Jak2 and DNMT1Dong Soon Choi, Elvin Blanco, Yoo-Shin Kim, et al.
BMC Cancer|August 15, 2024
Monitoring response to neoadjuvant chemotherapy in triple negative breast cancer using circulating tumor DNAJennifer H Chen, Sridevi Addanki, Dhruvajyoti Roy, et al.
Science Translational Medicine|December 15, 2021
A phase 1/2 clinical trial of the nitric oxide synthase inhibitor L-NMMA and taxane for treating chemoresistant triple-negative breast cancerAndrew W Chung, Kartik Anand, Ann C Anselme, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2018
Identification of Incidental Germline Mutations in Patients With Advanced Solid Tumors Who Underwent Cell-Free Circulating Tumor DNA SequencingThomas P Slavin, Kimberly C Banks, Darya Chudova, et al.
Pageof 2